Paul Tudor Jones Immatics N.V. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Immatics N.V. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 36,011 shares of IMTX stock, worth $247,755. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,011
Previous 51,379
29.91%
Holding current value
$247,755
Previous $597,000
31.32%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
101Shares Held
75.8MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$68.8 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$66.6 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$55.6 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$50.8 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$44.3 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $524M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...